Fausto Rinallo
Ethica Group
Nutrilinea S.r.l.
Deal Type
Company sale
Sector
Healthcare
Completion Date
25th September 2017
Deal Value
Not disclosed
Company Background
Nutrilinea is an Italian leading company in the contract manufacturing and packaging of food supplements and medical devices for the health and pharmaceutical industry.
Founded in 2002, the Company focuses on the development, manufacturing and packaging of health food supplements for both pharmaceutical and food companies. Today Nutrilinea has a product portfolio of more than 500 SKUs manufactured and packaged in solid dosage form. In 2018 it will launch the liquid dosage form production.
The Company’s state-of-the-art production plants are located in Gallarate (Northern Italy), where approximately 53 people are employed.
In 2016 the Company achieved €32 mln revenues with €5 mln EBITDA. In the first half of 2017 the growth trend was even more striking with a +66%.
Deal Summary
Ethica Corporate Finance advised the shareholders of R@S Consulting S.r.l., the holding company which controls Nutrilinea, in the sale to White Bridge Investments, an Italian private equity fund.
Value Added
The transaction process started with a strategic review leveraging on Ethica's knowledge of the Italian pharmaceutical market. Ethica was appointed by the shareholders of Nutrilinea to support and realize value through the exit, by managing a competitive sale process involving both trade and financial buyers.
Ethica was able to identify a selected panel of potential buyers, resulting from a pre-screening activity, and structure a competitive auction process which grants the highest net equity proceeds to the shareholder.
